Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Cell Rep ; 42(3): 112242, 2023 03 28.
Article in English | MEDLINE | ID: mdl-36924490

ABSTRACT

Here, we ask how developing precursors maintain the balance between cell genesis for tissue growth and establishment of adult stem cell pools, focusing on postnatal forebrain neural precursor cells (NPCs). We show that these NPCs are transcriptionally primed to differentiate and that the primed mRNAs are associated with the translational repressor 4E-T. 4E-T also broadly associates with other NPC mRNAs encoding transcriptional regulators, and these are preferentially depleted from ribosomes, consistent with repression. By contrast, a second translational regulator, Cpeb4, associates with diverse target mRNAs that are largely ribosome associated. The 4E-T-dependent mRNA association is functionally important because 4E-T knockdown or conditional knockout derepresses proneurogenic mRNA translation and perturbs maintenance versus differentiation of early postnatal NPCs in culture and in vivo. Thus, early postnatal NPCs are primed to differentiate, and 4E-T regulates the balance between cell genesis and stem cell expansion by sequestering and repressing mRNAs encoding transcriptional regulators.


Subject(s)
Neural Stem Cells , Cell Differentiation/physiology , Neural Stem Cells/metabolism , Neurons/metabolism , Processing Bodies , Protein Biosynthesis , Repressor Proteins/metabolism , RNA, Messenger/genetics , RNA, Messenger/metabolism , Nucleocytoplasmic Transport Proteins/metabolism
2.
eNeuro ; 7(3)2020.
Article in English | MEDLINE | ID: mdl-32349983

ABSTRACT

Peripheral nerves provide a supportive growth environment for developing and regenerating axons and are essential for maintenance and repair of many non-neural tissues. This capacity has largely been ascribed to paracrine factors secreted by nerve-resident Schwann cells. Here, we used single-cell transcriptional profiling to identify ligands made by different injured rodent nerve cell types and have combined this with cell-surface mass spectrometry to computationally model potential paracrine interactions with peripheral neurons. These analyses show that peripheral nerves make many ligands predicted to act on peripheral and CNS neurons, including known and previously uncharacterized ligands. While Schwann cells are an important ligand source within injured nerves, more than half of the predicted ligands are made by nerve-resident mesenchymal cells, including the endoneurial cells most closely associated with peripheral axons. At least three of these mesenchymal ligands, ANGPT1, CCL11, and VEGFC, promote growth when locally applied on sympathetic axons. These data therefore identify an unexpected paracrine role for nerve mesenchymal cells and suggest that multiple cell types contribute to creating a highly pro-growth environment for peripheral axons.


Subject(s)
Nerve Regeneration , Single-Cell Analysis , Axons , Ligands , Peripheral Nerves , Schwann Cells
3.
J Cell Biol ; 216(11): 3655-3675, 2017 11 06.
Article in English | MEDLINE | ID: mdl-28877995

ABSTRACT

Axon degeneration is an early event and pathological in neurodegenerative conditions and nerve injuries. To discover agents that suppress neuronal death and axonal degeneration, we performed drug screens on primary rodent neurons and identified the pan-kinase inhibitor foretinib, which potently rescued sympathetic, sensory, and motor wt and SOD1 mutant neurons from trophic factor withdrawal-induced degeneration. By using primary sympathetic neurons grown in mass cultures and Campenot chambers, we show that foretinib protected neurons by suppressing both known degenerative pathways and a new pathway involving unliganded TrkA and transcriptional regulation of the proapoptotic BH3 family members BimEL, Harakiri,and Puma, culminating in preservation of mitochondria in the degenerative setting. Foretinib delayed chemotherapy-induced and Wallerian axonal degeneration in culture by preventing axotomy-induced local energy deficit and preserving mitochondria, and peripheral Wallerian degeneration in vivo. These findings identify a new axon degeneration pathway and a potentially clinically useful therapeutic drug.


Subject(s)
Anilides/pharmacology , Crush Injuries/drug therapy , Mitochondria/drug effects , Neurons/drug effects , Neuroprotective Agents/pharmacology , Protein Kinase Inhibitors/pharmacology , Quinolines/pharmacology , Receptor, trkA/antagonists & inhibitors , Sciatic Nerve/drug effects , Sciatic Neuropathy/drug therapy , Wallerian Degeneration , Adrenergic Fibers/drug effects , Adrenergic Fibers/enzymology , Adrenergic Fibers/pathology , Animals , Apoptosis/drug effects , Apoptosis Regulatory Proteins/genetics , Apoptosis Regulatory Proteins/metabolism , Axons/drug effects , Axons/enzymology , Axons/pathology , Cells, Cultured , Crush Injuries/enzymology , Crush Injuries/genetics , Crush Injuries/pathology , Cytoprotection , Disease Models, Animal , Dose-Response Relationship, Drug , Genotype , Mice, Inbred C57BL , Mice, Transgenic , Mitochondria/enzymology , Mitochondria/pathology , Motor Neurons/drug effects , Motor Neurons/enzymology , Motor Neurons/pathology , Mutation , Neurons/enzymology , Neurons/pathology , Phenotype , Phosphorylation , Rats, Sprague-Dawley , Receptor, trkA/genetics , Receptor, trkA/metabolism , Sciatic Nerve/enzymology , Sciatic Nerve/injuries , Sciatic Nerve/pathology , Sciatic Neuropathy/enzymology , Sciatic Neuropathy/genetics , Sciatic Neuropathy/pathology , Sensory Receptor Cells/drug effects , Sensory Receptor Cells/enzymology , Sensory Receptor Cells/pathology , Signal Transduction , Superoxide Dismutase-1/genetics , Superoxide Dismutase-1/metabolism , Time Factors , Transcription, Genetic
SELECTION OF CITATIONS
SEARCH DETAIL
...